|
4 Companies |
|
1 Product |
|
1 Product |
|
3 Mechanisms of Action |
|
0 Trials |
|
38 News |
|
- | Trial completion: Visual Perceptual Learning for the Treatment of Visual Field Defect (clinicaltrials.gov) - Jan 17, 2019
P=N/A, N=36, Completed, Sponsor: Asan Medical Center
Recruiting --> Completed
- | Trial completion, Phase classification: VISIOTRAIN: Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach (clinicaltrials.gov) - Jul 27, 2018
P=N/A, N=22, Completed, Sponsor: Hospices Civils de Lyon
Recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P2 --> PN/A
- | Enrollment closed: VISIOTRAIN: Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach (clinicaltrials.gov) - Nov 13, 2017
P2, N=22, Active, not recruiting, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed | Phase classification: P2 --> PN/A Recruiting --> Active, not recruiting
- tropicamide / Generic mfg.
Trial completion, Trial primary completion date: Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients (clinicaltrials.gov) - May 2, 2017
P=N/A, N=8, Completed, Sponsor: Université de Montréal
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Sep 2016
- Trial primary completion date: VISIOTRAIN: Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach (clinicaltrials.gov) - Mar 25, 2016
P2, N=22, Recruiting, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Sep 2016 Trial primary completion date: May 2016 --> May 2018
- Trial completion, Enrollment change: Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas (clinicaltrials.gov) - Feb 18, 2016
P0, N=4, Completed, Sponsor: VA Office of Research and Development
Trial primary completion date: May 2016 --> May 2018 Active, not recruiting --> Completed | N=35 --> 4
- Enrollment closed: Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas (clinicaltrials.gov) - Aug 17, 2015
P0, N=35, Active, not recruiting, Sponsor: Department of Veterans Affairs
Active, not recruiting --> Completed | N=35 --> 4 Recruiting --> Active, not recruiting
- tropicamide / Generic mfg.
Enrollment closed, Trial primary completion date: Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients (clinicaltrials.gov) - Jun 3, 2015
P=N/A, N=8, Active, not recruiting, Sponsor: Université de Montréal
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Dec 2016
- Enrollment change, Trial withdrawal: Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=0, Withdrawn, Sponsor: Notal Vision Ltd
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> Dec 2016 N=50 --> 0 | Suspended --> Withdrawn
- Trial completion, Enrollment change, Trial primary completion date: A Study to Determine the Location of the Blind Spot and the Macula-disc Centre Distance on a Fundus Photograph (clinicaltrials.gov) - Feb 27, 2015
P=N/A, N=17, Completed, Sponsor: Turku University Hospital
N=50 --> 0 | Suspended --> Withdrawn Recruiting --> Completed | N=100 --> 17 | Trial primary completion date: Jan 2015 --> Aug 2014
- Trial primary completion date: Visual Perceptual Learning for the Treatment of Visual Field Defect (clinicaltrials.gov) - Jan 22, 2015
P=N/A, N=40, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Completed | N=100 --> 17 | Trial primary completion date: Jan 2015 --> Aug 2014 Trial primary completion date: Dec 2014 --> Dec 2017
- Trial primary completion date: VISIOTRAIN: Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach (clinicaltrials.gov) - Dec 10, 2014
P2, N=22, Recruiting, Sponsor: Hospices Civils de Lyon
Trial primary completion date: Dec 2014 --> Dec 2017 Trial primary completion date: Nov 2015 --> May 2016
- | Trial completion, Enrollment change: Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects (clinicaltrials.gov) - Oct 4, 2014
P=N/A, N=15, Completed, Sponsor: Notal Vision Ltd
Trial primary completion date: Nov 2015 --> May 2016 Active, not recruiting --> Completed | N=50 --> 15
- ||||||| Jetrea (ocriplasmin) / Oxurion
Trial completion, P3 data, Enrollment change: A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion (clinicaltrials.gov) - Sep 15, 2014
P3, N=252, Completed, Sponsor: Alcon Research
Active, not recruiting --> Completed | N=50 --> 15 Active, not recruiting --> Completed | N=168 --> 252
- tropicamide / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: Clinical Investigation on the Blood Oxygenation at the Optic Nerve Head in Fabry Patients (clinicaltrials.gov) - Sep 8, 2014
P=N/A, N=8, Recruiting, Sponsor: Université de Montréal
Active, not recruiting --> Completed | N=168 --> 252 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Aug 2014 | Trial primary completion date: May 2016 --> Aug 2016
- ||||| Jetrea (ocriplasmin) / Oxurion
Enrollment closed, P3 data: A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion (clinicaltrials.gov) - Mar 27, 2014
P3, N=168, Active, not recruiting, Sponsor: Alcon Research
Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Aug 2014 | Trial primary completion date: May 2016 --> Aug 2016 Recruiting --> Active, not recruiting
- Enrollment open: Visual Perceptual Learning for the Treatment of Visual Field Defect (clinicaltrials.gov) - Mar 15, 2014
P=N/A, N=40, Recruiting, Sponsor: Asan Medical Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || Enrollment change, HEOR, Metastases: GlaucomaEXPLOR: Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) (clinicaltrials.gov) - Dec 5, 2013
P=N/A, N=60, Completed, Sponsor: University Hospital Tuebingen
Not yet recruiting --> Recruiting N=20 --> 60
- ||| Trial completion, HEOR, Metastases: GlaucomaEXPLOR: Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) (clinicaltrials.gov) - Dec 5, 2013
P=N/A, N=60, Completed, Sponsor: University Hospital Tuebingen
N=20 --> 60 Recruiting --> Completed
- Trial suspension: Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) (clinicaltrials.gov) - Oct 27, 2013
P=N/A, N=50, Suspended, Sponsor: Notal Vision Ltd
Recruiting --> Completed Not yet recruiting --> Suspended
- Trial initiation date: Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas (clinicaltrials.gov) - Aug 15, 2013
P0, N=35, Recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Suspended Initiation date: Mar 2013 --> Jul 2013
- Enrollment open: Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas (clinicaltrials.gov) - Aug 15, 2013
P0, N=35, Recruiting, Sponsor: Department of Veterans Affairs
Initiation date: Mar 2013 --> Jul 2013 Not yet recruiting --> Recruiting
- |||||||||| Jetrea (ocriplasmin) / Oxurion
New P3 trial, P3 data: A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion (clinicaltrials.gov) - Jun 26, 2013
P3, N=168, Active, not recruiting, Sponsor: Alcon Research
- Enrollment open: A Study to Determine the Location of the Blind Spot and the Macula-disc Centre Distance on a Fundus Photograph (clinicaltrials.gov) - May 16, 2013
P=N/A, N=100, Recruiting, Sponsor: Turku University Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment change: Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) (clinicaltrials.gov) - May 15, 2013
P=N/A, N=10, Completed, Sponsor: Notal Vision Ltd
Not yet recruiting --> Recruiting N=50 --> 10
- Trial completion: Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) (clinicaltrials.gov) - May 15, 2013
P=N/A, N=10, Completed, Sponsor: Notal Vision Ltd
N=50 --> 10 Recruiting --> Completed
- Enrollment closed: Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects (clinicaltrials.gov) - May 13, 2013
P=N/A, N=50, Active, not recruiting, Sponsor: Notal Vision Ltd
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial termination: Evoked Retinal Response (clinicaltrials.gov) - Feb 28, 2013
P=N/A, N=1, Terminated, Sponsor: Columbia University
Recruiting --> Active, not recruiting Recruiting --> Terminated; Poor enrollment.
- Enrollment change: Evoked Retinal Response (clinicaltrials.gov) - Feb 28, 2013
P=N/A, N=1, Terminated, Sponsor: Columbia University
Recruiting --> Terminated; Poor enrollment. N=10 --> 1
- New P2 trial: VISIOTRAIN: Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach (clinicaltrials.gov) - Nov 19, 2012
P2, N=22, Recruiting, Sponsor: Hospices Civils de Lyon
- Clinical: Pilot-SINN: Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy (clinicaltrials.gov) - Jun 5, 2012
P=N/A, N=16, Completed, Sponsor: University Hospital Tuebingen
- Trial completion: The Use of Transcranial Direct Current Stimulation (TDCS) to Enhance the Rehabilitative Effect of Vision Restoration Therapy (clinicaltrials.gov) - Mar 19, 2012
P0, N=20, Completed, Sponsor: Beth Israel Deaconess Medical Center
N=10 --> 1 Active, not recruiting --> Completed
- Trial initiation date: Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) (clinicaltrials.gov) - Feb 1, 2012
P=N/A, N=50, Suspended, Sponsor: Notal Vision Ltd
Active, not recruiting --> Completed Initiation date: Jun 2011 --> Jun 2012
- | Trial completion: ValGATE: Validation of the GATE Software (clinicaltrials.gov) - Jan 17, 2012
P=N/A, N=30, Completed, Sponsor: University Hospital Tuebingen
Initiation date: Jun 2011 --> Jun 2012 Recruiting --> Completed